← boothcheck

ENSG vs PACS stock comparison

ENSIGN GROUP, INC vs PACS Group, Inc., two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

26.57 against 27.02: the multiples on these two skilled-nursing operators are as close as the sector prints, and everything underneath diverges. Ensign is the proven roll-up, 15.3% returns on equity on 0.06 turns of debt, a decade of buying broken facilities and fixing them; PACS is the newer, faster version, 23.4% returns on 0.24 turns, with a 7.2% free-cash yield to Ensign's 6.1%. Margins nearly match, 9% and 8.5% operating. The identical pricing says the market cannot decide between track record and torque, so it charges the same for both. Two versions of the same playbook at one price; the difference a buyer gets is vintage.

Comparison updated 2026-07-10.

ENSG vs PACS: the numbers

MetricENSGPACS
Price$163.16$41.88
Market cap$9.7B$6.8B
SectorMedical CareMedical Care
StageGrowthGrowth
Implied growth (priced in)+6.5%+7.9%
P/E26.627.0
P/B4.106.51
P/S1.841.25
EV/EBITDA16.717.8
Revenue growth+19.2%+23.6%
Operating margin9.0%8.4%
Net margin6.9%4.5%
Return on equity15.3%23.4%
Return on assets6.5%4.3%
Return on invested capital13.9%21.0%
FCF yield6.1%7.2%
Dividend yield0.1%0.5%
Debt / equity0.060.24
Current ratio1.560.99
Altman Z (solvency)3.372.01
Piotroski F (quality)7 / 97 / 9
Full ENSG report → Full PACS report →
Get boothcheck's read on ENSG and PACS, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.